DXR

Reports of a Study Comparing Daxor’s Direct Blood Volume Measurement With a Non-Invasive Hemoglobin Monitor in Critically Ill Surgical Patients

[Marketwired] – Daxor Corporation moreView todays social media effects on DXRView the latest stocks trending across Twitter. Click to view dashboardSee who Daxor is hiring next, click here to view […]

A Study Evaluating Hyponatremia Utilizing the BVA-100 Is Presented at Annual 2013 Critical Care Congress

[at noodls] – Christiana Medical Center, the largest hospital in Delaware, presented a study on the diagnosis of hyponatremia in critically ill neurologic patients. The authors were Drs. Kathryn Fulda, Timothy Manzone, … moreView todays social media effects on DXRView the latest stocks trending across Twitter. Click to view dashboardSee who Daxor is hiring next, click here to view […]

Reminder – Daxor (DXR) Goes Ex-Dividend Soon

moreView todays social media effects on DXRView the latest stocks trending across Twitter. Click to view dashboardSee who Daxor is hiring next, click here to view […]

Daxor Corporation Announces Payment of a Dividend

[at noodls] – Daxor Corporation (NYSE MKT: DXR), an investment company with medical instrumentation and biotechnology operations, announced the payment of a dividend today. The Board of Directors has approved payment … moreView todays social media effects on DXRView the latest stocks trending across Twitter. Click to view dashboard […]

Daxor Announces That PCI Nuclear Pharmacy Acquires BVA-100 Blood Volume Analyzer

[at noodls] – Daxor Corporation (NYSE MKT: DXR), a medical instrumentation and biotechnology company, today announced the receipt of a signed trial agreement from PCI Nuclear Pharmacy in Arizona. This agreement will … moreView todays social media effects on DXRView the latest stocks trending across Twitter. Click to view dashboard […]

Daxor Announces That PCI Nuclear Pharmacy Acquires BVA-100 Blood Volume Analyzer

[Marketwired] – Daxor Corporation , a medical instrumentation and biotechnology company, today announced the receipt of a signed trial agreement from PCI Nuclear Pharmacy in Arizona. This agreement will provide PCI with … moreView todays social media effects on DXRView the latest stocks trending across Twitter. Click to view dashboard […]

Daxor Announces Basic Blood Volume Research Study on Renal Dialysis Patients

[at noodls] – Daxor Corporation, (NYSE MKT: DXR) an investment company with medical instrumentation and biotechnology operations, today announced the presentation of a study on Radioisotope Blood Volume Measurement … moreView todays social media effects on DXRView the latest stocks trending across Twitter. Click to view dashboard […]